<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:newstin="http://newstin.com/rss/module" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>Newstin - SkyePharma</title>
    <link>http://www.newstin.co.uk/uk/SKYEPHARMA</link>
    <description>Organizing the News</description>
    <copyright>Copyright © 2006 I2S a.s.</copyright>
    <dc:rights>Copyright © 2006 I2S a.s.</dc:rights>
    <item>
      <title>SkyePharma - News</title>
      <link>http://www.newstin.co.uk/uk/SKYEPHARMA</link>
      <description>You are currently using FREE feeds from Newstin. You will get more data and services with Newstin Pro RSS licensed subscription.&lt;br/&gt;Newstin Pro RSS provides aggregated and categorized news content covering 1.25 Million news categories from 160.000 online sources in the format that can be easily integrated into environment or software of your choice. &lt;a href="http://corp.newstin.com/static.a?tpl=corp_rss"&gt;Read more about Newstin Pro RSS&lt;/a&gt; or &lt;a href="http://corp.newstin.com/files/corp/newstin_prorss.pdf"&gt;download the product presentation now&lt;/a&gt;.</description>
      <pubDate>Sun, 08 Nov 2009 01:53:49 GMT</pubDate>
      <guid>http://www.newstin.co.uk/uk/SKYEPHARMA</guid>
      <dc:date>2009-11-08T01:53:49Z</dc:date>
    </item>
    <item>
      <title>AssetCo’s victory from disaster with ten-year deal</title>
      <link />
      <description />
      <pubDate>Tue, 03 Nov 2009 12:58:47 GMT</pubDate>
      <guid />
      <dc:date>2009-11-03T12:58:47Z</dc:date>
    </item>
    <item>
      <title>London Markets: Miners, oil firms help FTSE 100 close 1% higher</title>
      <link />
      <description />
      <pubDate>Mon, 02 Nov 2009 16:58:00 GMT</pubDate>
      <guid />
      <dc:date>2009-11-02T16:58:00Z</dc:date>
    </item>
    <item>
      <title>SkyePharma: flutiform Phase III study complete</title>
      <link />
      <description />
      <pubDate>Mon, 02 Nov 2009 11:12:09 GMT</pubDate>
      <guid />
      <dc:date>2009-11-02T11:12:09Z</dc:date>
    </item>
    <item>
      <title>Beckerman Announces New Hire</title>
      <link />
      <description />
      <pubDate>Mon, 02 Nov 2009 10:05:28 GMT</pubDate>
      <guid />
      <dc:date>2009-11-02T10:05:28Z</dc:date>
    </item>
    <item>
      <title>Flutiform EU Clinical Trial Successfully Completed</title>
      <link />
      <description />
      <pubDate>Mon, 02 Nov 2009 10:24:00 GMT</pubDate>
      <guid />
      <dc:date>2009-11-02T10:24:00Z</dc:date>
    </item>
    <item>
      <title>UPDATE 1-SkyePharma: asthma drug meets goal; EU filing on track</title>
      <link />
      <description />
      <pubDate>Mon, 02 Nov 2009 12:24:55 GMT</pubDate>
      <guid />
      <dc:date>2009-11-02T12:24:55Z</dc:date>
    </item>
    <item>
      <title>Pacira's Phase III Study Of EXPAREL(TM) Meets Primary Pain Relief Endpoint</title>
      <link />
      <description />
      <pubDate>Wed, 21 Oct 2009 11:49:36 GMT</pubDate>
      <guid />
      <dc:date>2009-10-21T11:49:36Z</dc:date>
    </item>
    <item>
      <title>Reportlinker Adds Drug Delivery Markets: Oral Delivery Report</title>
      <link />
      <description />
      <pubDate>Thu, 24 Sep 2009 15:04:00 GMT</pubDate>
      <guid />
      <dc:date>2009-09-24T15:04:00Z</dc:date>
    </item>
    <item>
      <title>Research and Markets: Emerging Drug Formulation Technologies: Challenges and Opportunities</title>
      <link />
      <description />
      <pubDate>Mon, 14 Sep 2009 15:14:02 GMT</pubDate>
      <guid />
      <dc:date>2009-09-14T15:14:02Z</dc:date>
    </item>
  </channel>
</rss>

